International Experts Join Wuwei Heavy Ion Center Again—Solid Measures for High-Quality Development on Its Fifth Anniversary

Editor's Note: The fifth anniversary of the opening of the Wuwei Heavy Ion Center at Gansu Wuwei Cancer Hospital was celebrated, along with the successful hosting of the "2025 Academic Symposium on Cutting-Edge Technologies in Tumor Ion Therapy." Professor Tsujii hirohiko, Deputy Director of the National Institutes for Quantum Science and Technology (QST) Hospital in Japan and Director of the International Medical Center for Quantum Beam Therapy, Professor Shiro Fujisue, Director of the Prostate Cancer Center at Oshima Central Hospital in Japan and Visiting Assistant Professor in the Department of Urology at the University of the Ryukyus, and Professor Tan Hong Qi from the National Cancer Centre Singapore delivered insightful academic presentations at the symposium. The expert delegation also included Professor Ming Long Chao from the National Cancer Centre Singapore, Professor Wei Xuan Xu from the National Cancer Centre Singapore, and Professor Ru Xia Fan, President of Hue Central Hospital in Vietnam. As a significant initiative to drive high-quality development, the hospital's "Global Experts Rejoining" strategy achieved new breakthroughs, with multiple internationally renowned experts deeply engaging in academic exchanges and clinical practice, comprehensively elevating the hospital's heavy ion therapy to international standards. By continuously introducing top-tier international radiation oncology experts and establishing a global academic exchange platform, the hospital promotes the dissemination and application of advanced international radiation therapy technologies and expertise, providing patients with higher-quality, more efficient, and more precise radiation therapy services.

On June 29, Professor Shiro Saito, a renowned Japanese expert newly joining our hospital, joined forces with Professor Tsujii hirohiko, who has been long-term employed by the hospital, to provide in-depth clinical guidance at the Wuwei Heavy Ion Center. This collaboration serves as a vivid example of the solid implementation of our hospital's key high-quality development initiative—the "Global Experts Rejoining" strategy.

The two experts conducted clinical guidance across various radiotherapy departments at the Wuwei Heavy Ion Center. During ward rounds, Professor Tsujii hirohiko and Professor Shiro Saito meticulously reviewed each patient's medical history and examined their diagnostic reports. Drawing on their extensive clinical experience and profound expertise, they provided precise analyses of the patients' conditions and tailored personalized treatment recommendations and optimization plans based on individual cases. In discussions with the radiotherapy department's medical staff, the two experts shared cutting-edge international radiotherapy techniques, concepts, and clinical practices. They engaged in in-depth exchanges on the precise application of radiotherapy technologies and the optimization of treatment workflows. They also commended the hospital's achievements in oncology treatment while offering valuable suggestions for improvement where needed. The medical staff expressed that this ward-round guidance was highly enlightening, broadening their academic perspectives and exposing them to advanced diagnostic and therapeutic techniques and concepts. They noted that the experience would significantly enhance their professional skills and ability to provide better patient care.

Wuwei Heavy Ion Center of Gansu Wuwei Cancer Hospital takes "Pooling Global Resources to Empower Healthy China" as its strategic core, continuously advancing heavy ion therapy technology through five high-quality development initiatives. After thirteen years of construction and five years of stable operation, the center has established eight global firsts, setting a benchmark for China. By optimizing its pricing model, the center has activated the inclusive potential of heavy ion medical services. It promotes clinical research in heavy ion therapy, establishing Chinese guidelines aligned with international standards. The center has systematically compiled and disseminated a series of authoritative books on heavy ion therapy, leading the industry toward standardized development. Actively advancing global alliances, the center has strengthened the foundation for high-quality development. It continues to deepen the "Global Experts Rejoining" strategy, forming an international expert think tank covering the entire heavy ion therapy value chain.

The in-depth clinical practice and academic guidance provided by Professors Tsujii hirohiko and Shiro Saito represent not only a profound integration of cutting-edge international medical expertise but also a powerful testament to the solid implementation of the high-quality development strategy of the Wuwei Heavy Ion Center at Gansu Wuwei Cancer Hospital. As a key practice of the "Global Experts Rejoining" initiative, the hospital has established a talent strategy that combines recruitment and cultivation, continuously aggregating top-tier global medical resources to build an international expert network covering the entire heavy ion diagnosis and treatment chain. Leveraging the synergistic innovation advantages of its dual heavy ion centers and multiple globally leading diagnostic and therapeutic achievements, the hospital will continue to advance its high-quality development path. With international collaboration as a bridge and innovation as the driving force, the hospital is committed to building a globally influential heavy ion medical hub, establishing "China's solutions" as a benchmark in the field of precision oncology worldwide, and providing patients across the globe with superior, state-of-the-art healthcare services.